Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 117 publications
Retraction: In vivo NCL targeting affects breast cancer aggressiveness through miRNA regulation.
Journal: The Journal of experimental medicine
Published: June 30, 2026
A multicenter, phase I/II trial of anastrozole, palbociclib, trastuzumab, and pertuzumab in hormone receptor (HR)-positive, HER2-positive metastatic breast cancer (ASPIRE).
Journal: Journal of the National Cancer Institute
Published: March 24, 2026
Randomized phase II comparison of single-agent carboplatin versus combination of carboplatin and everolimus for advanced triple negative breast cancer.
Journal: Breast cancer research and treatment
Published: May 16, 2025
Phase II study of MEK inhibitor trametinib alone and in combination with AKT inhibitor GSK2141795/uprosertib in patients with metastatic triple negative breast cancer.
Journal: Breast cancer research and treatment
Published: July 27, 2024
Surface Passivation by Quantum Exclusion: On the Quantum Efficiency and Stability of Delta-Doped CCDs and CMOS Image Sensors in Space.
Journal: Sensors (Basel, Switzerland)
Published: October 13, 2023
Associations of Early Completion of Advance Directives With Key End-of-Life Quality Measures: Analysis of an ASCO Quality Oncology Practice Initiative Patient Cohort.
Journal: JCO oncology practice
Published: January 20, 2023
Transportation barriers, emergency room use, and mortality risk among US adults by cancer history.
Journal: Journal of the National Cancer Institute
Published: November 21, 2022
When cancer survivors are also caregivers: well-being of "dual-role" cancer survivors.
Journal: Journal of cancer survivorship : research and practice
Published: July 04, 2022
Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis.
Clinical outcomes of de novo metastatic HER2-low breast cancer: a National Cancer Database Analysis.
Journal: NPJ breast cancer
Published: June 10, 2022
Bigger isn't always better: the ESMO dose de-intensification guideline framework.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: April 26, 2022
Self-reported Transportation Barriers to Health Care Among US Cancer Survivors.
Journal: JAMA oncology
Published: March 24, 2022
Last Updated: 09/26/2026